Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brunella Barbaro

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Brachytherapy|March 21, 2025
High-Tailored Anal canal Radiotherapy (HIT-ART): Long term results of MR image-guided interventional radiotherapy (brachytherapy) boostLuca Tagliaferri, Stefania Manfrida, Bruno Fionda, et al.
Journal of Contemporary Brachytherapy|December 2, 2015
MITHRA - multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: a feasibility studyLuca Tagliaferri, Stefania Manfrida, Brunella Barbaro, et al.
Clinical and Translational Radiation Oncology|March 18, 2021
Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysisGiuditta Chiloiro, Elisa Meldolesi, Martina Giraffa, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2002
Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patientsVincenzo Valentini, Claudio Coco, Aurelio Picciocchi, et al.
La Radiologia Medica|November 2, 2021
Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model developmentGiuditta Chiloiro, Davide Cusumano, Paola de Franco, et al.
The British Journal of Radiology|November 16, 2016
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic diseaseBrunella Barbaro, Lucia Leccisotti, Fabio M Vecchio, et al.
Frontiers in Oncology|December 21, 2020
Delta Radiomics Can Predict Distant Metastasis in Locally Advanced Rectal Cancer: The Challenge to Personalize the CureGiuditta Chiloiro, Pablo Rodriguez-Carnero, Jacopo Lenkowicz, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2008
Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092)Vincenzo Valentini, Antonino De Paoli, Maria Antonietta Gambacorta, et al.
Tumori|June 15, 2007
Sphincter preservation in four consecutive phase II studies of preoperative chemoradiation: analysis of 247 T3 rectal cancer patientsMaria Antonietta Gambacorta, Vincenzo Valentini, Claudio Coco, et al.
Clinical and Translational Radiation Oncology|June 22, 2018
Phase I and II trial on infusional 5-fluorouracil and gefitinib in combination with preoperative radiotherapy in rectal cancer: 10-years median follow-upMaria Antonietta Gambacorta, Antonino De Paoli, Marco Lupattelli, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Brachytherapy|March 21, 2025
High-Tailored Anal canal Radiotherapy (HIT-ART): Long term results of MR image-guided interventional radiotherapy (brachytherapy) boostLuca Tagliaferri, Stefania Manfrida, Bruno Fionda, et al.
Journal of Contemporary Brachytherapy|December 2, 2015
MITHRA - multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: a feasibility studyLuca Tagliaferri, Stefania Manfrida, Brunella Barbaro, et al.
Clinical and Translational Radiation Oncology|March 18, 2021
Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysisGiuditta Chiloiro, Elisa Meldolesi, Martina Giraffa, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2002
Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patientsVincenzo Valentini, Claudio Coco, Aurelio Picciocchi, et al.
La Radiologia Medica|November 2, 2021
Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model developmentGiuditta Chiloiro, Davide Cusumano, Paola de Franco, et al.
The British Journal of Radiology|November 16, 2016
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic diseaseBrunella Barbaro, Lucia Leccisotti, Fabio M Vecchio, et al.
Frontiers in Oncology|December 21, 2020
Delta Radiomics Can Predict Distant Metastasis in Locally Advanced Rectal Cancer: The Challenge to Personalize the CureGiuditta Chiloiro, Pablo Rodriguez-Carnero, Jacopo Lenkowicz, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2008
Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092)Vincenzo Valentini, Antonino De Paoli, Maria Antonietta Gambacorta, et al.
Tumori|June 15, 2007
Sphincter preservation in four consecutive phase II studies of preoperative chemoradiation: analysis of 247 T3 rectal cancer patientsMaria Antonietta Gambacorta, Vincenzo Valentini, Claudio Coco, et al.
Clinical and Translational Radiation Oncology|June 22, 2018
Phase I and II trial on infusional 5-fluorouracil and gefitinib in combination with preoperative radiotherapy in rectal cancer: 10-years median follow-upMaria Antonietta Gambacorta, Antonino De Paoli, Marco Lupattelli, et al.
Pageof 6